TARPON SPRINGS, Fla., June 13, 2005 (PRIMEZONE) -- Regaltech, Inc. (Pink Sheets:RGTH), a holding company dedicated to stem cell research and development, announced that it is exploring various acquisition opportunities to further fuel the growth and development of the Company.
"We are just starting to scratch the surface of potential applications of stem cell technology," remarked Regaltech President Preston Valentine, "and we strongly feel that no other industry provides the unique investment opportunity poised by ongoing research and development in this area. Dramatic developments in this area are in the news on virtually a daily basis and our company is dedicated to trying to achieve a leadership position in the development and exploitation of this amazing new technology."
The Company
Regaltech Holdings, Inc. is a holding company dedicated to stem cell research and development, publicly traded under the ticker symbol RGTH. Regaltech is pursuing synergistic, value-added opportunities in the field stem cell research with the potential for achieving high-growth returns for our investors.
This news release contains forward-looking statements regarding Regaltech's business strategies and future plans of operations. Forward-looking statements involve known and unknown risk and uncertainties. The company's risks and uncertainties include: intense price competition, economic, political and regulatory uncertainties, the need to raise additional capital for growth and expansion and its reliance on the Internet as a means for promoting the software it sublicenses. The forward-looking statements contained in this news release speak only as of the date hereof and Regaltech disclaims any obligation to provide public updates, revisions or amendments to any forward-looking statements made herein to reflect changes in Regaltech's expectations or future events.